In this regard, the in silico evaluation of ADAM33 as one of the chief causative parameters of asthma was undertaken to investigate the potential risk of ADAM33 polymorphisms from the vast number of neutral SNPs of the ADAM33 gene in the induction of asthma disorder according to the available databases as well as to attain a more dependable outcome. The gene discussed is ADAM33; the disease is asthma.